Clinical acceptance of software based on artificial intelligence
  technologies (radiology) by Morozov, S. P. et al.
CLINICAL ACCEPTANCE OF SOFTWARE BASED ON 
ARTIFICIAL INTELLIGENCE TECHNOLOGIES 
(RADIOLOGY)
Preprint № CDT-2019-1
GOVERNMENT OF MOSCOW
DEPARTMENT OF HEALTH CARE OF MOSCOW
RESEARCH AND PRACTICAL CLINICAL CENTER
OF DIAGNOSTICS AND TELEMEDICINE TECHNOLOGIES,
DEPARTMENT OF HEALTH CARE OF MOSCOW
Moscow 2019 
2ISSN 2618-7124
UDC 615.84+ 616-073.75
LBC 53.6
K-49
Developer: Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, 
Department of Health Care of Moscow
Authors: 
Morozov S.P. – MD, MPH, PhD, Professor, CEO of the Research and Practical Clinical Center of Diagnostics 
and Telemedicine Technologies, Department of Health Care of Moscow, Chief Regional Radiology and 
Instrumental Diagnostics Officer, Department of Health Care of Moscow, Chief Regional Radiology and 
Instrumental Diagnostics Officer in the Central Federal District of the Russian Federation, Ministry of 
Health of the Russian Federation
Vladzymyrskyy A.V. – MD, PhD, Deputy Director for science of the Research and Practical Clinical Center 
of Diagnostics and Telemedicine Technologies, Department of Health Care of Moscow
Klyashtornyy V.G. – PhD, Analyst at the Department of Scientific Activity Coordination, Research and 
Practical Clinical Center of Diagnostics and Telemedicine Technologies, Department of Health Care of 
Moscow
Andreychenko A.E. – PhD, Senior Researcher at the Department of Technical Monitoring and Quality 
Assurance Development, Research and Practical Clinical Center of Diagnostics and Telemedicine 
Technologies, Department of Health Care of Moscow
Kulberg N.S. – PhD, Head of the Department of Medical Imaging Tools Development, Research and 
Practical Clinical Center of Diagnostics and Telemedicine Technologies, Department of Health Care of 
Moscow
Gombolevsky V.A. – MD, PhD, Head of the Department of Radiology Quality Development, Research 
and Practical Clinical Center of Diagnostics and Telemedicine Technologies, Department of Health Care 
of Moscow
 
K-49 S.P. Morozov, A.V. Vladzymyrskyy, V.G. Klyashtornyy, A.E. Andreychenko, N.S. Kulberg, V.A. 
Gombolevsky. Clinical acceptance of software based on artificial intelligence technologies (radiology). 
Preprint № CDT-2019-1 / Series “Best practices in medical imaging”. – Issue 23. – M., 2019. – 27 p.
Aim: provide a methodological framework for the process of clinical acceptance of algorithms and 
software based on the artificial intelligence (“AI”) technologies. The acceptance is considered as a 
preparation stage for the software registration as a medical product. The authors describe approaches 
to evaluate accuracy and efficiency of the AI algorithms for radiology.
All rights reserved. The material may not be reproduced or distributed, in whole or in part, without the prior 
written permission of the Department of Health Care of Moscow. However, reproduction and distribution, 
in whole or in part, by non-profit, research or educational institutions for their own use is permitted with full 
citation and copyright acknowledgement.
For correspondence: info@npcmr.ru, npcmr@zdrav.mos.ru
28/1, Srednyaya Kalitnikovskaya st., Moscow, 109029, Russia
+7 (495) 276-04-36
© Department of Health Care of Moscow, 2019
© Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, 
Department of Health Care of Moscow, 2019
© Writing team, 2019
Best practices in medical imaging
3
CONTENTS
 
Normative references............................................................................................................................................4
Glossary...................................................................................................................................................................5
Symbols and abbreviations................................................................................................................................6
Introduction.............................................................................................................................................................7
The Main part. Basic framework.....................................................................................................................8
Stages of clinical evaluation............................................................................................................................10
Metrics of clinical evaluation..........................................................................................................................11
Reference data requirements........................................................................................................................16
Result registration.................................................................................................................................................17
Conclusion................................................................................................................................................................18
References...............................................................................................................................................................19
Annex 1........................................................................................................................................................................20
Annex 2........................................................................................................................................................................25
Best practices in medical imaging
4
NORMATIVE REFERENCES
The document has references to the following regulatory documents 
(standards):
1. Federal Law of 21.11.2011 No. 323-FZ “On the basis of health protection in the 
Russian Federation”.
2. Federal Law of 27.07.2006 No. 152-FZ “On Personal Data”.
3. Federal Law of 27.07.2006 No. 149-FZ “On Information, Digital Technologies and 
Data Protection”.
4. Federal Law of 27.12.2002 No. 184-FZ “On Technical Regulation”.
5. Decree of the President of the Russian Federation of 09.05.2017 No. 203 “On the 
Strategy for the Information Society Development in the Russian Federation for 
2017-2030”.
6. Regulation of the Government of the Russian Federation of 27.12.2012 No. 1416 
“On the Approval of Rules for the State Registration of Medical Products”.
7. Regulation of the Government of the Russian Federation of 05.05.2018 No. 555 
“On the Unified State Information System in the Field of Health Care”.
8. Order of the Ministry of Health Care of the Russian Federation of 09.01.2014 No. 
2n “On the Approval of Assessing the Conformity of Medical Devices in the Form 
of Technical Tests, Toxicological Studies, Clinical Tests for the State Registration of 
Medical Devices”.
9. Order of the Ministry of Health Care of the Russian Federation of 01.04.2016 No. 
200n “On the Approval of Rules of Good Clinical Practice”.
10. Order of the Department of Health Care of Moscow of 25.12.2017 No. 918 “On 
the Regulations for Data Registration in the Unified Radiological Information 
Service in Medical Centers of the State Health System in Moscow”.
11. GOST R ISO 14155-2014 “Clinical Studies. Good Clinical Practice” (order of 
Rostekhregulirovanie of 04.06.2014 No. 497-st).
12. Letter of the Federal Service for Supervision in the Field of Health Care of 
30.12.2015 No. 01I-2358/15 “On Software Registration”.
13. Methodical recommendations on the order of assessing the quality, efficiency 
and safety of medical devices (in terms of software) for the state registration 
under the national system / M.: State Budgetary Institution “All-Russian Scientific 
Research Institute of Medical Equipment” of Roszdravnadzor, 2018. – 31 p.
Best practices in medical imaging
5
GLOSSARY
The document contains the following terms with appropriate definitions:
Medical dataset (reference data) is a collection of high-level attributes of reusable 
medical image datasets suitable to train, test, validate, verify, and regulate AI 
algorithms.
Intellectual technologies are information technologies created based on “artificial 
intelligence”.
“Artificial Intelligence” (AI) refers to systems that display intelligent behavior by 
analyzing their environment and taking actions – with some degree of autonomy 
– to achieve specific goals. AI-based systems can be purely software-based, acting 
in the virtual world (e.g., voice assistants, image analysis software, search engines, 
speech and face recognition systems) or AI can be embedded in hardware devices 
(e.g., advanced robots, autonomous cars, drones, or Internet of Things applications) 
[6].
Mathematical model is an abstract mathematical representation of a process, 
device or concept; it uses a number of variables to represent inputs, outputs and 
internal states, and sets of equations and inequalities to describe their interaction.
Machine learning 1. A field in computer science that builds computational models 
that have the ability of “learning” from the data and then provide predictions. 
Depending on whether there is a supervisory signal, machine learning can be 
divided into three categories: the supervised learning, unsupervised learning, and 
reinforcement learning. 2. A technology for automatic learning in recognition and 
classification with test datasets to improve pattern detection, processing, and 
forecasting.
Activation threshold (“cut-off” point) is a predefined value, which triggers the 
algorithm (for example, the presence of a pathology).
Labelling / tagging is a standardized process of recording the pathological 
changes on diagnostic images to a database; the process includes lesion localization 
and nature, pathology reports, data extracted from unstructured text, and other 
information; several qualified medical specialists independently perform the process 
for each image or study.
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SYMBOLS AND ABBREVIATIONS
 
URIS – Unified Radiological Information Service
AI – “Artificial intelligence”
IT – Information technologies
MO – Medical organization
SO – Software
RIS – Radiology Information System
RF – Russian Federation
CAMI – centralized archive of medical images
AUC – Area Under Curve
CE – Conformité Européenne
CONSORT – Consolidated Standards of Reporting Trials
FDA – Food and Drug Administration
PACS – Picture Archiving and Communication System
ROC – Receiver Operating Characteristic
FROC – Free Response Operating Characteristic
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INTRODUCTION 
 
“Artificial Intelligence” is a research field that focuses on a hardware or software 
modeling of human activities traditionally considered to be intellectual. AI is a part of 
computer sciences. New technologies are related to information technologies. The 
concept of “artificial intelligence”, however, is not novel. An automated analysis of 
medical information has long-existing scientific and practical applications. In recent 
years, there was an explosive growth in a new generation of intelligent technologies 
due to significant progress in computing power and mathematics. “Artificial 
Intelligence” has the potential to solve many problems in medical diagnostics 
(decision support, morphometry, workflow automation, quality control, etc.). Before 
routine use, AI-based systems must undergo clinical trials to evaluate the diagnostic 
accuracy and obtain a status of the medical device.
Although legislative nuances may vary, in the Russian Federation medical 
device is defined per the Federal Law of No. 323 signed 21.11.2011. A medical device 
is any tool, device, equipment, materials and other products used for medicinal 
purposes (separately or in combination with each other), as well as accessories 
necessary for the use of the products mentioned before, including specialized 
software. Medical devices are designed for prevention, diagnosis, treatment, and 
medical rehabilitation, patient monitoring, medical studies, restoring, replacing, 
changing anatomy or physiology, preventing, or terminating a pregnancy. The 
functionality of a medical device is not based on pharmacological, immunological, 
genetic, or metabolic effects on the human body.
Any software that influences the doctor’s decision-making, or provides 
clinically valuable information, carries a potential risk and thereby may cause harm 
to patients’ health. Therefore, such software, including AI-based solutions, is subject 
to the registration as a medical device. Testing clinical effectiveness is an obligatory 
stage before submitting such software for registration as a medical device. These 
methodological guidelines form a unique approach for assessing the diagnostic 
efficacy of software with clinical tests. Moreover, an AI-based software can be used 
both independently or complementary to the other medical devices.
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THE MAIN PART
Basic framework
In diagnostics, “Artificial Intelligence” is a multidisciplinary area that combines 
medicine, biology, mathematics, and computer science and modeling the individual 
components of doctors’ intellectual activities (Table 1).
Table 1. AI in radiology: application areas.
Primary tasks AI use case Standard medical task
Object’s presence Detection
Screening, mass preventive 
examinations
Object type Classification Determining lesion’s nature
Object size and 
morphology
Segmentation, volumetry, 
radiomics
Medical morphometry (lesion 
follow-up, automatic generation 
of the image descriptors)
Speech and text 
recognition
Natural language 
processing
Logging, quality control
After an AI-based algorithm has successfully passed clinical tests, medical staff 
should strictly regulate its use as a decision support system. Medical professionals 
may use the results generated by the algorithm. “Artificial intelligence” is aimed at 
improving the efficiency of the healthcare system, staff productivity, reducing risks 
and errors, standardizing diagnostic results.
The AI-based software should undergo clinical acceptance before registration 
as a medical device per Article 36.1 of the Federal Law No. 323. The acceptance tests 
determine whether the software’s accuracy and safety comply with the specifications 
stated by developers.
According to Article 38 of the Federal Law No. 323, a medical device is any 
tool, device, equipment, materials and other products used for medicinal purposes 
(separately or in combination with each other), as well as accessories necessary for 
the use of the products mentioned before, including a specialized software. Medical 
devices are designed for prevention, diagnosis, treatment, and medical rehabilitation, 
patient monitoring, medical studies, restoring, replacing, changing anatomy or 
physiology, preventing, or terminating a pregnancy. The functionality of a medical 
device is not based on pharmacological, immunological, genetic, or metabolic 
effects on the human body. Medical products can be considered interchangeable 
if they are comparable in functionality, quality, and technical characteristics, and can 
replace each other.
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Per the Letter of the Federal Service for Supervision in Health Care, a state 
marketing authorization is obligatory for medical devices and software intended for1:
• controlling and monitoring equipment usage;
• receiving, storing and processing diagnostic data in an automatic mode;
• monitoring human body functions and transmitting the data (including 
wireless technologies);
• calculating dosage parameters (radiation, drugs, contrast medium, etc.);
• processing and transferring the data from the diagnostic medical equipment 
to the therapy systems;
• processing medical images (including quality, color, resolution modification, 
etc.);
• three-dimensional modeling (dentistry, prosthetics, orthopedics, 
implantology, organ, and bone prototyping, etc. [2]);
• communication between the diagnostic and therapeutic equipment;
• processing digital images.
Also, it should be noted that the “software” refers to medical devices in the 
following cases [2]:
• processing, storing and transferring medical records;
• providing medical care via telemedicine;
• installation as part of an information system for home care;
• data processing for the electronic registration of medical equipment, medical 
devices used in hospitals;
• ensuring communication between patients and medical specialists, so 
that a patient can follow a treatment per the rules defined when using the 
application, and for population monitoring;
• installation as a part of a blood bank information system, single station or 
decentralized network.
Preliminary testing
Before an algorithm gets the status of a medical device, the “artificial 
intelligence” may be used for pilot projects, research works, and trials. These activities 
are allowed if the algorithm meets the following criteria (Annex 1). The criteria form a 
technical specification, creating a set of requirements for the AI-based software. Also, 
developers should state application purposes (Table 1) for a particular modality, use 
case and workflow.
______________________________
1 Letter of the Federal Service for Supervision in the Field of Health Care of 30.12.2015 
No. 01I-2358/15 “On Software Registration”
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Thus, AI-based algorithms and software used in radiology belong to medical 
devices and must undergo clinical trials. The software can be used independently or 
in combination with other products (both hardware and software, for example, URIS, 
PACS, RIS, etc.). A preliminary deployment of an AI algorithm is possible if developers 
meet the methodological criteria.
Stages of clinical evaluation
Clinical acceptance tests are organized per current legislation and 
methodology for assessing the quality, effectiveness, and safety of medical devices. 
AI-based software should be evaluated on the clinical relationship (validity) between 
selected data and algorithm (concept, measurement, conclusion) per the intended 
purpose [2].
The clinical evaluation of software that is based on “artificial intelligence” and 
intended for use in radiology is carried out in two stages (Figure 1): 
1. Analytical validation: Evaluating the performance with reference data.
2. Clinical validation: Evaluating the performance in a routine workflow.
Clinical acceptance
Clinical validationAnalytical validation
QUESTION
ACTION
BASIC METRICS
Does the software achieve 
its goals for the target 
population in the clinical 
workflow?
Does the software correctly 
process input data to create 
reliable output data?
1. Comparative 
chronometry of the 
operating process and its 
individual stages.
2. Retrospective analysis 
(audit) of the diagnostic 
results, the coefficient of the 
classification consistency.
1. Creating and analyzing 
the characteristic curve (e.g. 
ROC-curve).
2. Criteria of the diagnostic 
accuracy.
3. Similarity coefficient.
4. Coefficient of the 
classification consistency.
Using software within a 
standard operating process
Using software to analyze 
the reference data
Figure 1 – Flowchart for a clinical evaluation of the AI-based software in radiology. 
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The first stage is done by generating and analyzing diagnostic data for the 
intended use of software:
• a medical dataset is created;
• an automated analysis is performed, imitating a diagnostic process;
• the results are compared to the reference tagging in the dataset;
• a mathematical and statistical analysis is performed.
The importance of the first stage is 90-95%.
The second stage is software deployment in a routine workflow. Procedures 
performed with the help of AI-based algorithm are evaluated for performance and 
quality. That includes multiple timing studies involving several medical specialists at 
the varying day times and shifts and retrospective analysis of the AI-based algorithm 
results. The possible risks of the second stage should be minimized, providing safety 
for patients and their legal representatives. 
The importance of the second stage is 5-10%.
A protocol of clinical acceptance should include:
• details on the medical dataset (reference data), including the state registration 
certificate, data type/volume, tagging information;
• information about the software installation process in the medical center;
• information on the use of computing power provided by the developer;
• information on the uninstallation process after the test completion (since the 
software is installed and used on the equipment before receiving a registration 
certificate).
In general, the software should be predesigned according to the checklist 
(Annex 2).
Metrics of the clinical evaluation
Analytical validation
An analytical stage consists of designing the diagnostic study and is assessed 
with the standard metrics.
The index test is an automated analysis of medical data by the AI-based 
software.
The dataset tagging, which was performed according to the methodology, is 
used as a reference test.
A confusion matrix is built to compare the index and reference tests. It 
contains the absolute values for each comparison (Table 2). Then, the developers 
should select and calculate the relevant metrics (Table 3) with the reliability within 
95% of the confidence interval.
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Table 2. AI-based software in radiology: results combined to the confusion matrix.
Result type
True positive True negative False-positive False-negative
TP TN FP FN
The software 
revealed pathology 
when it’s present
The software did not 
reveal pathology in 
its absence
The software 
revealed pathology 
in its absence
The software did not 
reveal pathology 
when it’s present
Table 3. Typical metrics for the analytical evaluation.
AI use case Basic metrics
Detection The standard set of metrics
Classification The standard set of metrics
Segmentation Similarity coefficient
Natural language processing Classification consistency ratio 
Various combinations of metrics can be used depending on the problem 
to be solved, for instance, ROC analysis and classification consistency ratio. Basic 
indicators, such as sensitivity, specificity, AUC should be used to define each type of 
“artificial intelligence” result.
Standard set of metrics
Standard metrics are used to compare the diagnostic performance of index 
test relative to the reference test (Table 4).
Table 4. The standard set of diagnostic metrics.
Indicator Value Formula
Sensitivity The probability that the index 
test is positive in the presence 
of pathology
TP / (TP + FN)
Specificity The probability that the index 
test is negative in the absence 
of pathology
TN / (TN + FP)
Accuracy (general 
validity) 
Level of correspondence (the 
index test to the reference test)
(TP + TN) / (TP + TN + FP 
+ FN)
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The likelihood ratio of a 
positive result 
The mathematical relation 
between the probability of 
presence and absence of the 
target pathology with positive 
index test 
sensitivity / (1-specificity)  
The likelihood ratio of a 
negative result 
The mathematical relation 
between the probability of 
presence and absence of the 
target pathology with negative 
index test 
(1-sensitivity) / specificity 
Positive predictive value  Likelihood of pathology with 
positive index test
TP / (TP + FP)
Negative predictive value Likelihood of the absence of 
pathology with negative index 
test
TN / (TN + FN)
All metrics, except the likelihoods, are evaluated in the range of 0-1 or in 
percentage from 0 to 100%:
Evaluation
<0.6 – unsuitable
0.61 - 0.8 – revision required
> 0.81 – admissible for clinical validation
The likelihood ratio of a positive result should be as large as possible whereas 
the likelihood ratio of a negative result should be as small as possible.
Characteristic curve (ROC/FROC)
A receiver operating characteristic curve is a graphical plot illustrating the 
diagnostic ability of a binary classifier system as its discrimination threshold is varied. 
The ROC curve is created by plotting the true positive rate against the false positive 
rate. It is a metric of diagnostic value: area under the curve (AUC) – area bounded by 
(F)ROC-curve and horizontal coordinate.
Classic ROC-curve: грa diagram that illustrates the dependence of sensitivity 
on 1-specificity (1-specificity on the horizontal coordinate and sensitivity on the 
vertical coordinate).
In addition to the classic curve, we recommend calculating a ROC-curve, 
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based on the predictive value: dependence of a positive predictive value on 
1-negative predictive value (1-negative predictive value on the horizontal axis and 
the positive predictive value on the vertical axis). Such ROC-curve may be beneficial 
in some cases, as it considers the prevalence of the pathology in population.
When analyzing these ROC-curves, it is necessary to determine the “cut-off” 
values. We recommend to use two techniques:
1) minimum distance from the upper left corner to the ROC-curve (d minimum);
2) Youden index, revealing the maximum distance from the diagonal line to the ROC-
curve (Figure 2). The “cut-off” should be defined per the research objectives.
minimum d
se
ns
iti
vi
ty
Yo
ud
en
 In
de
x
1 - specicity
Figure 2 – Determining the optimal cut-off value.
ROC-curve with a free response (FROC-curve): a diagram that illustrates 
the dependence of sensitivity to false positive rate (horizontal axis is for the number 
of false positive cases, and the vertical axis is for sensitivity).
The area under the curve (AUC) is evaluated in the range of 0-1:
Evaluation
<0.6 – unsuitable
0.61 - 0.8 – revision required
> 0.81 – admissible for clinical validation
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Classification Consistency Ratio
The consistency (concordance) is a mathematical definition of the agreement 
between two experts regarding a single phenomenon.
The formula, according to Cohen’s method (Cohen’s kappa) (Cohen J., 1960):
K= (P0 - Pe) / (1 - Pe),
where P
0
 is the proportion of cases where the measurements coincided, and 
P
e
 is the expected proportion of cases with random coincidence. Calculations are as 
follows:
Expert #1
Expert #2
1 2 Total
1 p
11
p
12
p
1_
2 p
21
p
22
p
2_
Total p
_1
p
_2
1
P0 = P11 + P22
Pe = P_1P1_ + P_2P2_
It is evaluated in the range of 0-1 or in percentage from 0 to 100%:
Evaluation
<0.6 – unsuitable
0.61 - 0.8 – revision required
> 0.81 – admissible for clinical validation
Similarity coefficient
Binary indicator to quantify the similarity degree of biological objects. The 
formula, according to Dice-Sörensen’s method (Dice L., 1945 Sörensen T., 1948):
DSC=2|A
U
B|/(|A|+|B| )
where the numerator is twice the number of matched estimates, and the 
denominator is the total number of estimates.
For sets with the same power, it is evaluated in the range of 0-1:
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Evaluation
<0.6 – unsuitable
0.61 - 0.8 – revision required
> 0.81 – admissible for clinical validation
Clinical validation
Timing study is a method of evaluating the software’s effectiveness by 
recording and measuring the duration of actions performed within a workflow. For 
example, the report turnaround time of a screening chest radiography with and 
without an AI-based solution.
An audit is a retrospective analysis with the goal of quality assurance. In 
radiology, the audit of AI-based algorithm is performed to determine the agreement 
with the recommended standards [4]. The audit allows assessing the quality of 
medical aid, including the diagnostics with and without AI; the significance of 
differences is determined statistically.
Reference Data Requirements
For the analytical stage of clinical tests, reference data is needed.
Dataset is a structured set of diagnostic data, including diagnostic images and 
information on pathological changes on images; structured cases of medical care 
and related electronic medical documents from electronic medical records; libraries 
of keywords, phrases and their critical combinations, data of genetic tests, as well as 
combinations of various medical data, combined into a depersonalized patient (the 
so-called “digital twin”). If the database contains confirmed information on the final 
diagnosis for each case or confirmed pathological process, then it is called “verified”.
The medical dataset is used for the analytical validation of an AI-based 
software in radiology.
A specialized medical research organization should audit the dataset.
We recommend using a dataset with the state registration for clinical tests.
The reference medical dataset should contain the following information:
1) state registration certificate number;
2) population characteristics (gender and age, race, geographic, etc.); depersonalization 
data; medical centers sourcing the database formation;
3) imaging study characteristics (anatomical region(s), modality, diagnostic device, 
study protocol);
4) target pathology per the International Classification of Diseases;
5) the total number of clinical cases, studies, images, reports and their distribution in 
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diagnostic groups;
6) the normal-to-abnormal ratio (“pathology” cases can be divided into several 
subcategories);
7) verification data (histopathological or other “final” diagnosis);
8) tagging methodology (scientific publications, guidelines, or patents).
The reference medical database should meet the following requirements:
1) the normal-to-abnormal ratio should reflect the prevalence of the target pathology 
in the population;
2) several medical centers should source the medical dataset to introduce the data 
heterogeneity;
3) demographic, socio-economic characteristics and basic health indicators in the 
dataset should correspond to the population’s average characteristics in the target 
region;
4) the proposed size of the dataset should be justified per statistical considerations, 
and the desired diagnostic accuracy by the main metrics indicated above.
 Result registration
In the evaluation of clinical tests, the following should be considered:
• the software is tested with the dataset and on all necessary equipment 
(including other medical devices) designed to ensure the proper functioning 
of the AI-based software;
• clinical tests should utilize all software modules and functions per the 
developer’s specification;
• all items of evidence-based software should be assessed (clinical data, 
interchangeable medical devices, etc.), as submitted by the developer to the 
medical testing organization;
• the medical organization conducting the clinical tests must evaluate the 
software’s documentation, including the technical requirements, accessibility/
clarity to the relevant specialists, as the contents must ensure a proper, 
effective and safe intended use.
The results for any medical device should be registered. In Russian Federation, 
registration is carried out per the order of the Ministry of Health dated January 9th, 
2014 No. 2n “On the Approval of Assessing the Conformity of Medical Devices in the 
Form of Technical Tests, Toxicological Studies, Clinical Tests for the State Registration 
of Medical Devices”.
We recommend creating the documentation with the detailed report of data 
evaluation and analysis per the updated STARD 2015 checklist (Annex 2).
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CONCLUSION 
Some algorithms and tools based on intelligent technologies have already 
been successfully used in medical imaging/radiology. Further development of 
“artificial intelligence” should be targeted at solving specific problems.
The implementation of these recommendations allows for unifying clinical 
acceptance of an AI-based software in radiology. Such tests are a mandatory 
component for the registration of as a medical device.
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Annex 1
 
Criteria for the admission of AI to a preliminary test operation
 
1. Goals:
• The software provides a preliminary automatic analysis of medical images to 
improve the quality and speed of the radiology workflow;
• The software ensures a prioritization in the worklist according to the 
automatically revealed pathology;
• The software provides a preliminary comparative analysis of studies of a single 
patient at different time points (dynamic study);
• The software provides support in medical decisions;
• The software automatically prepares a draft of the radiology report based on 
the results of the analysis. 
2. Certification:
• Approvals of FDA and / or CE certification (class II); actual implementations 
of the currently working software in medical centers: at least 2 independent 
institutions; more than 6 months of operation; at least 1000 successfully 
completed studies (confirmed by radiologists) for each task (if the software 
solves several tasks);
• Scientific articles (original research works) published in peer-reviewed journals 
indexed by “Scopus” and / or “Web of Science” and included in the first and 
second quartile according to the “International Scientific Journal & Country 
Ranking”;
• Proven diagnostic accuracy AUC>=0,8 (classic ROC curve) and increase of the 
radiology workflow efficiency (based on the comparison of reporting speed 
with and without the software, including timing);
• Availability or willingness to undergo the procedure of state registration as a 
medical device in the Russian Federation.
3. Security:
• Compliance with the requirements of the legislation of the Russian Federation 
in the field of personal data, information security and health protection;
• Availability or readiness to deploy server capacities necessary for software 
operation within the Russian Federation.
4. Evidence:
• Once the development was completed, the accuracy of algorithms was 
assessed on independent data1;
______________________________
1 The medical database for testing was different from the database used for training, 
calibration and validation of the system (that is, testing was performed on data that 
the algorithm had not previously encountered)
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• Diagnostic accuracy tested on population whose characteristics are similar to 
those where the AI is intended to be used;
• Annual update of diagnostic accuracy information.
5. Standardization:
• Automated analysis of diagnostic images in DICOM standard; 
• Support of the HealthLevel7 (HL7) / FHIR standard (in particular, the system 
should provide an exchange of messages on the completion of automatic 
image analysis, pathology detection and classification);
• Use of recommended classifications (RADS, MAGNIMS, etc.) when making 
reports.
6. Integration:
• Availability or readiness to develop means for “seamless” integration with 
information systems working in the field of health care of the given subject of 
the Russian Federation, medical information systems;
• Availability or willingness to develop tools for integration with “AGFA Enterprise 
Imaging” radiological information system or similar ones;
• Availability of tools for integration with PACS and RIS (DICOM “query and 
retrieve”);
• Possibility of “seamless” integration with PACS / RIS, provided only by software.
7. Functionality:
• Ability of stream processing and subsequent sending of series to PACS, 
extended with the results of the AI analysis;
• Possibility to combine series of native images and those containing the results 
of the AI analysis;
• Identification of findings (nosologies, pathological signs, deviations from 
norm) for a given modality or working process according to the technical 
specifications;
• Classification (determination of type and variety) of findings, including by 
ICD-10 if required by the technical specifications;
• Providing information on the likelihood of target pathology;
• Automatic preparation and uploading of a draft of findings description to 
PACS (subject to the structure of description template preinstalled in PACS);
• Automatic analysis result displayed by standard PACS tools, including DICOM 
graphics capabilities;
• Availability of description protocol templates with their automatic generation 
and sending to RIS / MIS via HL7 / FHIR messages;
• Availability of a built-in accuracy assessment tool;
• Possibility of an additional training of algorithm basing on “real world” data;
• Max. 60 seconds for processing of a single radiology study without considering 
the time for data transfer. When evaluating the dynamics (comparing the 
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studies), the analysis may take more than 60 seconds, but not more than 60 
seconds for one study;
• Control function ensuring the start of the automated analysis only after 
receiving the “status complete by radiographer” HL7 message from RIS;
• HL7 software reports on the completion of automated analysis and pathology 
detection for the prioritization of studies in the worklist;
• Possibility of automated search for similar studies for comparison in the PACS 
/ RIS database;
• For each analyzed study, the software generates a declaration containing 
the software (algorithm) name, a list of the revealed findings (nosologies, 
pathological signs, deviations from norm) with indication of sensitivity and 
specificity for each type; the declaration is formed in DICOM SR, Overlay etc., 
and transmitted to PACS as a separate series;
• The result of software operation is series of images (DICOM format), with:
a) a number of slices similar to those in the original series for a simultaneous 
viewing by radiologist;
b) information on each slice contains the software name, version, 
diagnostic accuracy, the verification date and the exact time of completed 
study;
c) possibility to provide additional series with the analysis results (e.g. 
summary tables with the revealed findings in dynamics and / or particular 
images of findings).
8. Contract:
• The developer must have a quality management system;
• The developer must have a version preparation and control policies;
• Regular system updates, including those for diagnostic accuracy information;
• Software updates included in the price;
• All medical data, related materials and software results are the property of the 
customer.
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Questionnaire for the admission of software based on “artificial 
intelligence” / computer vision to a preliminary test operation
Section Metrics Answer 
(1-yes / 
0-no)
Comments
1. Goals 1.1. The software provides a preliminary 
automatic analysis of medical images 
(DICOM files) to improve the quality and 
speed of the radiology workflow.
1.2. The software ensures a prioritization in 
the worklist according to the automatically 
revealed pathology.
1.3. The software automatically prepares a 
draft of the radiology report based on the 
results of the analysis.
1.4. The software provides a preliminary 
comparative analysis of studies of a single 
patient at different time points (dynamic 
study).
2. Certification 2.1. Approvals of FDA and / or CE certification 
(class II).
If the answer to clause 2.1 is “no”, there should 
be positive answers to clauses 2.2 and 2.3.
2.2. Actual implementations of the currently 
working software in medical centers:
- at least 2 independent institutions;
- more than 6 months of operation;
- at least 1000 successfully completed 
studies (confirmed by radiologists) for each 
task (if the software solves several tasks).
2.3. Scientific articles (original research 
works) published in peer-reviewed journals 
indexed by “Scopus” and / or “Web of 
Science” and included in the first and second 
quartile according to the “International 
Scientific Journal & Country Ranking”; 
proven diagnostic accuracy AUC>=0,8 
(classic ROC curve) and increase of the 
radiology workflow efficiency (based on the 
comparison of reporting speed with and 
without the software, including timing).
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3. Evidence 3.1. Once the development was completed, 
the accuracy of algorithms was assessed 
on independent data, i.e. medical database 
for testing differed from the one used for 
training, development and validation. That 
is, clinical tests were performed on data 
unknown to the algorithms.
3.2. Diagnostic accuracy was tested on data 
that included Caucasoid and Mongoloid 
races.
3.3. Annual update of diagnostic accuracy 
information.
4. Functionality 4.1. Availability of a built-in accuracy 
assessment tool (if applicable).
4.2. Max. 60 seconds for processing of a 
single radiology study without considering 
the time for data transfer. To accomplish the 
goal 1.4, the analysis may take more than 60 
seconds, but not more than 60 seconds for 
one study.
4.3. The result of software operation is series 
of images (DICOM format), with:
• a number of slices similar to those in 
the original series for a simultaneous 
viewing by radiologist;
• information on each slice contains the 
software name, version, diagnostic 
accuracy, the verification date and the 
exact time of completed study;
• possibility to provide additional series 
with the analysis results (e.g. summary 
tables with the revealed findings in 
dynamics and / or particular images of 
findings).
5. Contract 5.1. Regular system updates, including those 
for diagnostic accuracy information.
5.2. Software updates included in the price.
5.3. All medical data, related materials and 
software results are the property of the 
customer.
Best practices in medical imaging
25
Annex 2
 
Checklist for a detailed description of the results of clinical acceptance 
of software developed for radiology based on intelligent technologies 
(according to STARD 2015 [7] with addenda)
Section and 
topic
No Item
TITLE
1 Emphasis on assessing the diagnostic accuracy of software 
based on intelligent technologies designed for radiology
ABSTRACT
2 Structured summary of study design, materials and 
methods, results, and conclusions
INTRODUCTION
3 Scientific and clinical data, including the intended use and 
clinical role of the index test
4 Study objectives, hypotheses and endpoints
METHODS
Study design 5 Prospective or retrospective study 
(whether data collection was planned before the index 
test and reference standard were performed or after
Sampling 6 Eligibility criteria (including targeted pathology)
7 On what basis participants were identified (such as 
symptoms, results from previous tests, etc.)
8 Where and when the medical database was formed 
(incl. key characteristics: state registration, population 
characteristics, data depersonalization, targeted pathology 
and diagnostic groups distribution, studies characteristics, 
verification, labelling methodology)
9 Planned sampling size and way of it’s calculating
10a The sampling was formed sequentially, randomly or in 
other ways. Justification of sampling size
Test methods 10b Index test, in sufficient detail to allow replication
(including information on mathematical models, neural 
networks, machine learning methods, samplings for 
training and calibration used in the development process)
11 Reference test (“gold standard”), in sufficient detail to allow 
replication (the reference test is a reference data labelling)
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12a Rationale for choosing the reference test (labelling 
methodology, the whole reference data base)
12b The activation threshold (“cut-off” point) of the index test, 
including distinguished pre-specified result categories 
from exploratory. Method of determining the activation 
threshold: the minimum distance from the upper left 
corner to the ROC-curve, Youden index (depending on the 
study objectives)
13a The activation threshold (threshold rules decision, “cut-off”) 
of the reference test, including distinguished pre-specified 
result categories from exploratory. Method of determining 
the activation threshold: the minimum distance from 
the upper left corner to the ROC-curve, Youden index 
(depending on the study objectives)
13b Whether critical clinical and laboratory information and 
reference standard results were available to the performers 
/ analysts of the index test (blind study or not; in the 
second case the reason should be justified)
14 Whether critical clinical and laboratory information and 
index test results were available to the participants of 
labelling / analysis of the reference data (blind study or 
not; in the second case the reason should be justified)
Analysis 15 Methods for estimating or comparing measures of 
diagnostic accuracy (metrics)
16 How indeterminate index test or reference standard results 
were handled
17 How missing data on the index test and reference standard 
were handled
18 Any analyses of variability in diagnostic accuracy, 
distinguishing pre-specified from exploratory
RESULTS
Participants 19 Patients characteristics: flow of participants, population for 
analysis, number of patients included in the study, number 
of prematurely withdrawn patients, number of skipped 
or unusable data. In addition to the text description it is 
recommended to provide a CONSORT diagram
20 Baseline demographic and clinical characteristics of 
sampling (when performing the initial survey; all subjects, 
as well as subjects with results of both tests)
21a РDistribution of severity of disease in those with the target 
condition
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21b Distribution of alternative diagnoses in those without 
the target condition (according to the International 
Classification of Diseases)
22 Any significant differences in the methods of the index test 
and reference test
Test results 23 Combined table of index test and reference test results
24 Estimates of diagnostic accuracy and their precision (such 
as 95% confidence intervals)
25 Any adverse events from performing the index test or the 
reference standard
DISCUSSION
26 Study limitations, including sources of potential bias, 
statistical uncertainty, and generalisability
27 Implications for practice, including the intended use and 
clinical role of the index test
OTHER 
INFORMATION
28 Registration number and name of registry (any stage)
29 Where the full study protocol can be accessed (including 
medical database information for training and calibration) 
30 Sources of funding and other support; role of funders
